Join Now

Yearly Archives: 2022

Sen. Lee Introduces Bill to Increase Patient Access to Biosimilars

By Denise Bell | Published November 22, 2022

On November 17, Sen. Mike Lee (R-UT) introduced the “Biosimilar Red Tape Elimination Act” to increase patient access to biosimilars and reduce costs by easing switching studies required to allow a biosimilar to be substituted for a biologic. View a one-page summary HERE. Currently, pharmacists can substitute generics in lieu of their branded counterparts without […]

Posted in Policy News | Leave a comment

NEW DIGITAL HEALTH INITIATIVE TO CREATE NEXT GENERATION OF MEDICAL APPS, GAMES, AND TECHNOLOGIES

By Natalie Themm | Published November 22, 2022

The University of Utah Health has launched NEW DIGITAL HEALTH INITIATIVE

Posted in BioUtah News | Tagged | Leave a comment

Teva Announces Appointment of Richard Francis as President and CEO

By Natalie Themm | Published November 21, 2022

Kåre Schultz to Retire After a Transformative Five-Year Tenure Setting the Stage for an Exciting Future

Posted in BioUtah News | Tagged | Leave a comment

Myriad Genetics Announces UroSuite™, an Industry-First Suite of Genetic Tests for Prostate Cancer, Giving Urologists Access to Timely, Data-driven Medical Information

By admin | Published November 17, 2022

SALT LAKE CITY, Nov. 10, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the launch of UroSuite, a comprehensive suite of genetic risk assessment tests that cover every stage of prostate cancer care. UroSuite includes Myriad’s Prolaris® Prostate Cancer Test, MyRisk™ Hereditary Cancer Test, […]

Posted in BioUtah News | Leave a comment

CenExel Creates Clinical Sciences Business Unit

By Natalie Themm | Published November 15, 2022

CenExel announces a new Clinical Sciencesbusiness unit and more.

Posted in BioUtah News | Tagged | Leave a comment

BioHive Summit Recap

By admin | Published November 12, 2022

On Thursday, November 10, 2022, the BioHIve gathered at the Salt Palace for the annual BioHive Summit presented by Mayer Brown. It was the first time in three years the industry had gathered in person. The pent up demand for in-person networking combined with quality programming resulted in record registration of over 700 participants. Governor […]

Posted in BioUtah News | Leave a comment

Betty Iverson Retirement

By Natalie Themm | Published November 11, 2022

Betty Iverson Retirement Announced

Posted in BioUtah News | Tagged | Leave a comment

PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business Update

By Natalie Themm | Published November 11, 2022

PolarityTE provided a business update and reported financial results for the quarterly period ended September 30, 2022.

Posted in BioUtah News | Tagged | Leave a comment

PolarityTE Confirms Receipt of Unsolicited, Non-Binding Offer to Acquire the Company

By Natalie Themm | Published November 9, 2022

PolarityTE confirmed that on November 1, 2022, it received an unsolicited, non-binding offer (followed by an amended offer on November 8, 2022) from Michael Brauser to acquire all of the outstanding common stock of the Company not owned by him for $1.25 per share in cash.

Posted in BioUtah News | Tagged | Leave a comment

Clene Announces $10.8 Million Registered Direct Offering and $5 Million Debt Facility from the State of Maryland

By Natalie Themm | Published November 2, 2022

Clene announced that it has entered into a securities purchase agreement with certain existing stockholders.

Posted in BioUtah News | Tagged | Leave a comment

Clene Reports Topline Results Demonstrating Survival Signal for CNM-Au8® in Healey ALS Platform Trial

By Natalie Themm | Published November 2, 2022

The primary endpoint of adjusted ALSFRS-R and secondary endpoints of CAFS and SVC were not met at 24 weeks Prespecified exploratory analyses of the secondary survival endpoint for the 30 mg dose demonstrated a >90% reduction in risk of death or risk of death/permanently assisted ventilation at 24 weeks Survival signal consistent with prior results […]

Posted in BioUtah News | Tagged | Leave a comment

Myriad Genetics Expands Consumer Access to Genetic Testing with Acquisition of Gateway Genomics and Its Market-Leading SneakPeek® Early Gender DNA Test

By Natalie Themm | Published November 2, 2022

$67.5 million tuck-in acquisition strengthens Myriad’s Women’s Health portfolio of prenatal products.

Posted in BioUtah News | Tagged | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members